PRMT5-IN-23

PRMT5-IN-23 (compound 50) is a potent and selective PRMT5 inhibitor with demonstrated anti-tumor activity. This small molecule is a valuable research tool for investigating epigenetic mechanisms in oncology, supporting both in vitro biochemical assays and in vivo efficacy studies in preclinical cancer models.